150 related articles for article (PubMed ID: 23225569)
1. Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-β1 processing.
Wottawa M; Leisering P; Ahlen Mv; Schnelle M; Vogel S; Malz C; Bordoli MR; Camenisch G; Hesse A; Napp J; Alves F; Kristiansen G; Farhat K; Katschinski DM
Int J Cancer; 2013 Jun; 132(12):2787-98. PubMed ID: 23225569
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
4. Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis.
Bordoli MR; Stiehl DP; Borsig L; Kristiansen G; Hausladen S; Schraml P; Wenger RH; Camenisch G
Oncogene; 2011 Feb; 30(5):548-60. PubMed ID: 20856199
[TBL] [Abstract][Full Text] [Related]
5. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression.
McMahon S; Charbonneau M; Grandmont S; Richard DE; Dubois CM
J Biol Chem; 2006 Aug; 281(34):24171-81. PubMed ID: 16815840
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
Huang KT; Mikeska T; Dobrovic A; Fox SB
Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
[TBL] [Abstract][Full Text] [Related]
9. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling.
Pientka FK; Hu J; Schindler SG; Brix B; Thiel A; Jöhren O; Fandrey J; Berchner-Pfannschmidt U; Depping R
J Cell Sci; 2012 Nov; 125(Pt 21):5168-76. PubMed ID: 22946054
[TBL] [Abstract][Full Text] [Related]
10. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
11. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.
Su Y; Loos M; Giese N; Metzen E; Büchler MW; Friess H; Kornberg A; Büchler P
Cancer; 2012 Feb; 118(4):960-72. PubMed ID: 21792862
[TBL] [Abstract][Full Text] [Related]
12. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
Takeda K; Fong GH
Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
[TBL] [Abstract][Full Text] [Related]
13. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.
Schultz K; Murthy V; Tatro JB; Beasley D
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L921-7. PubMed ID: 19304911
[TBL] [Abstract][Full Text] [Related]
14. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
Peurala E; Koivunen P; Bloigu R; Haapasaari KM; Jukkola-Vuorinen A
Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
[TBL] [Abstract][Full Text] [Related]
15. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
[TBL] [Abstract][Full Text] [Related]
16. Periostin inhibits hypoxia-induced apoptosis in human periodontal ligament cells via TGF-β signaling.
Aukkarasongsup P; Haruyama N; Matsumoto T; Shiga M; Moriyama K
Biochem Biophys Res Commun; 2013 Nov; 441(1):126-32. PubMed ID: 24129188
[TBL] [Abstract][Full Text] [Related]
17. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer.
Kozlova N; Wottawa M; Katschinski DM; Kristiansen G; Kietzmann T
Oncotarget; 2017 Feb; 8(6):9885-9898. PubMed ID: 28038470
[TBL] [Abstract][Full Text] [Related]
19. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
Zhao Y; Zeng H; Liu B; He X; Chen JX
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
